| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 4.33e-04 | 11 | 57 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 6.12e-04 | 13 | 57 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 6.12e-04 | 13 | 57 | 2 | GO:0016803 | |
| GeneOntologyBiologicalProcess | type 2 immune response | 1.30e-05 | 55 | 54 | 4 | GO:0042092 | |
| Domain | IL-17_fam | 1.13e-04 | 6 | 52 | 2 | IPR010345 | |
| Domain | IL17 | 1.13e-04 | 6 | 52 | 2 | PF06083 | |
| Domain | VDCC_gsu | 2.11e-04 | 8 | 52 | 2 | IPR008368 | |
| Domain | PLAC | 1.26e-03 | 19 | 52 | 2 | IPR010909 | |
| Domain | PLAC | 1.26e-03 | 19 | 52 | 2 | PS50900 | |
| Domain | Homeobox_CS | 1.78e-03 | 186 | 52 | 4 | IPR017970 | |
| Domain | ADAM_spacer1 | 1.85e-03 | 23 | 52 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.85e-03 | 23 | 52 | 2 | PF05986 | |
| Domain | Homeobox_metazoa | 2.02e-03 | 90 | 52 | 3 | IPR020479 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.02e-03 | 24 | 52 | 2 | IPR013273 | |
| Domain | Homeobox | 4.06e-03 | 234 | 52 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 4.18e-03 | 236 | 52 | 4 | PS00027 | |
| Domain | HOX | 4.25e-03 | 237 | 52 | 4 | SM00389 | |
| Domain | Homeobox_dom | 4.38e-03 | 239 | 52 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 4.38e-03 | 239 | 52 | 4 | PS50071 | |
| Domain | Peptidase_M12B_N | 5.27e-03 | 39 | 52 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.27e-03 | 39 | 52 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 5.54e-03 | 40 | 52 | 2 | PS00427 | |
| Domain | PMP22_Claudin | 5.54e-03 | 40 | 52 | 2 | PF00822 | |
| Domain | ADAM_MEPRO | 5.54e-03 | 40 | 52 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.54e-03 | 40 | 52 | 2 | PS50214 | |
| Domain | Reprolysin | 5.54e-03 | 40 | 52 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 5.54e-03 | 40 | 52 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 5.82e-03 | 41 | 52 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 5.82e-03 | 41 | 52 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 6.38e-03 | 43 | 52 | 2 | IPR001818 | |
| Domain | UBA | 6.67e-03 | 44 | 52 | 2 | IPR015940 | |
| Domain | PMP22/EMP/MP20/Claudin | 6.97e-03 | 45 | 52 | 2 | IPR004031 | |
| Domain | UBA | 7.59e-03 | 47 | 52 | 2 | PS50030 | |
| Domain | - | 7.90e-03 | 283 | 52 | 4 | 1.10.10.60 | |
| Pathway | WP_IL17_SIGNALING | 6.62e-05 | 32 | 35 | 3 | M39560 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 22608496 | ||
| Pubmed | The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. | 1.67e-08 | 4 | 57 | 3 | 19155512 | |
| Pubmed | 4.16e-08 | 5 | 57 | 3 | 30962593 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20303295 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11927536 | ||
| Pubmed | IL-17E (IL-25) and IL-17A Differentially Affect the Functions of Human Keratinocytes. | 2.64e-06 | 2 | 57 | 2 | 31958433 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31072819 | ||
| Pubmed | IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. | 2.64e-06 | 2 | 57 | 2 | 25092341 | |
| Pubmed | T cell-derived Act1 is necessary for IL-25-mediated Th2 responses and allergic airway inflammation. | 2.64e-06 | 2 | 57 | 2 | 21856933 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17475805 | ||
| Pubmed | IL-17 enhances chemokine gene expression through mRNA stabilization. | 2.64e-06 | 2 | 57 | 2 | 17785852 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 21749686 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 26320658 | ||
| Pubmed | Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. | 7.91e-06 | 3 | 57 | 2 | 27030211 | |
| Pubmed | The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. | 7.91e-06 | 3 | 57 | 2 | 19155511 | |
| Pubmed | Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer. | 7.91e-06 | 3 | 57 | 2 | 30334403 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 35277002 | ||
| Pubmed | Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity. | 7.91e-06 | 3 | 57 | 2 | 21722219 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 22161142 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 19968632 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23957336 | ||
| Pubmed | ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. | 7.91e-06 | 3 | 57 | 2 | 33723527 | |
| Pubmed | MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A. | 7.91e-06 | 3 | 57 | 2 | 27180111 | |
| Pubmed | Regnase-1 degradation is crucial for IL-33- and IL-25-mediated ILC2 activation. | 7.91e-06 | 3 | 57 | 2 | 31990689 | |
| Pubmed | MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation. | 1.58e-05 | 4 | 57 | 2 | 27920272 | |
| Pubmed | IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation. | 1.58e-05 | 4 | 57 | 2 | 29625134 | |
| Pubmed | Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells. | 1.58e-05 | 4 | 57 | 2 | 23995070 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 27075243 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 31074012 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 28581022 | ||
| Pubmed | Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. | 1.58e-05 | 4 | 57 | 2 | 18762568 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 26356122 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 31239234 | ||
| Pubmed | Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. | 2.63e-05 | 5 | 57 | 2 | 25888259 | |
| Pubmed | Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. | 2.63e-05 | 5 | 57 | 2 | 23123062 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 20139273 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 22797925 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 23042150 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 17982039 | ||
| Pubmed | The H2.0-like homeobox transcription factor modulates yolk sac vascular remodeling in mouse embryos. | 2.63e-05 | 5 | 57 | 2 | 24764455 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 29101209 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19825828 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 28561022 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 26371249 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 22649194 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 20554964 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 25026213 | ||
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 22942422 | ||
| Pubmed | Calcium channel gamma subunits provide insights into the evolution of this gene family. | 5.51e-05 | 7 | 57 | 2 | 11738816 | |
| Pubmed | 7.23e-05 | 263 | 57 | 5 | 20932939 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ITPRIPL2 LATS2 ADAMTS7 NFX1 SAC3D1 ZNF579 FAAP100 REPIN1 ADCY7 | 7.29e-05 | 1105 | 57 | 9 | 35748872 |
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 7.34e-05 | 8 | 57 | 2 | 17652770 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 16530167 | ||
| Pubmed | Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. | 7.34e-05 | 8 | 57 | 2 | 26431948 | |
| Pubmed | The induction and function of the anti-inflammatory fate of TH17 cells. | 7.34e-05 | 8 | 57 | 2 | 32620760 | |
| Pubmed | IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis. | 9.43e-05 | 9 | 57 | 2 | 27956525 | |
| Pubmed | A Conserved LIR Motif in Connexins Mediates Ubiquitin-Independent Binding to LC3/GABARAP Proteins. | 9.43e-05 | 9 | 57 | 2 | 32272685 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 11170751 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 21822258 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 24120361 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 15977181 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 15576406 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 20139090 | ||
| Pubmed | TRIM33 HOXC5 ITPRIPL2 FAT3 NKX2-6 ZNF579 FAAP100 REPIN1 PCK2 | 1.50e-04 | 1215 | 57 | 9 | 15146197 | |
| Pubmed | 1.55e-04 | 709 | 57 | 7 | 22988430 | ||
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 17259303 | ||
| Pubmed | Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart. | 1.72e-04 | 12 | 57 | 2 | 17050624 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.72e-04 | 12 | 57 | 2 | 25770910 | |
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 2.03e-04 | 13 | 57 | 2 | 20941780 | |
| Pubmed | Identification of downstream genetic pathways of Tbx1 in the second heart field. | 2.03e-04 | 13 | 57 | 2 | 18328475 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 30824326 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 23255421 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 18345009 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 31366290 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 28732025 | ||
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 20929948 | ||
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 15459098 | ||
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 11572777 | ||
| Pubmed | Compartmentalized metabolism supports midgestation mammalian development. | 3.53e-04 | 17 | 57 | 2 | 35388219 | |
| Pubmed | Chromatin remodelling complex dosage modulates transcription factor function in heart development. | 3.53e-04 | 17 | 57 | 2 | 21304516 | |
| Pubmed | Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. | 4.43e-04 | 19 | 57 | 2 | 20651287 | |
| Pubmed | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. | 4.43e-04 | 19 | 57 | 2 | 26347139 | |
| Pubmed | 4.92e-04 | 20 | 57 | 2 | 21350214 | ||
| Pubmed | The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. | 4.92e-04 | 20 | 57 | 2 | 12370779 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 5.19e-04 | 95 | 57 | 3 | 29643511 | |
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 31286141 | ||
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 27383629 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 6.06e-04 | 235 | 57 | 4 | 28378594 | |
| Pubmed | Failure of extra-embryonic progenitor maintenance in the absence of dosage compensation. | 6.53e-04 | 23 | 57 | 2 | 22573614 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 6.86e-04 | 908 | 57 | 7 | 19274049 | |
| Pubmed | WD40 repeat and FYVE domain containing 3 is essential for cardiac development. | 7.73e-04 | 25 | 57 | 2 | 30428088 | |
| Pubmed | 9.02e-04 | 27 | 57 | 2 | 21983003 | ||
| Pubmed | Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. | 9.71e-04 | 28 | 57 | 2 | 15901664 | |
| Pubmed | Specification of jaw identity by the Hand2 transcription factor. | 9.71e-04 | 28 | 57 | 2 | 27329940 | |
| Pubmed | Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. | 9.71e-04 | 28 | 57 | 2 | 37846569 | |
| Pubmed | 1.19e-03 | 31 | 57 | 2 | 15843414 | ||
| Pubmed | 1.19e-03 | 31 | 57 | 2 | 29099309 | ||
| Pubmed | 1.27e-03 | 32 | 57 | 2 | 31815296 | ||
| Pubmed | NOTCH maintains developmental cardiac gene network through WNT5A. | 1.27e-03 | 32 | 57 | 2 | 30347193 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 1.27e-03 | 32 | 57 | 2 | 31434798 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 7.19e-04 | 19 | 38 | 2 | 50 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.35e-03 | 26 | 38 | 2 | 253 | |
| GeneFamily | Endogenous ligands|Interleukins | 3.68e-03 | 43 | 38 | 2 | 601 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FOXJ2 CIDEB ZC3H12A PPP1R3E ZFHX3 FAAP100 SLC4A5 REPIN1 ZYX BTN2A1 ADCY7 | 3.38e-06 | 905 | 57 | 11 | M40865 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 8.55e-06 | 634 | 57 | 9 | M40866 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_200 | 2.36e-05 | 67 | 53 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k3_200 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.70e-06 | 192 | 57 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-06 | 194 | 57 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.13e-05 | 127 | 57 | 4 | df2854bcb2708ddc13b3ca48c03887380e827790 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 148 | 57 | 4 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.76e-05 | 156 | 57 | 4 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-05 | 163 | 57 | 4 | e526104a3a574ee860078ce7c049e7fec9443f37 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-05 | 60 | 57 | 3 | 48adafeec1810bce5f118fa63d4a8ee7ab9ca0f7 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-05 | 60 | 57 | 3 | a83afb89dbfc2e1cdfce57320d89c980bd8fb820 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.65e-05 | 170 | 57 | 4 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-05 | 179 | 57 | 4 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-05 | 179 | 57 | 4 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-05 | 179 | 57 | 4 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 184 | 57 | 4 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.22e-05 | 185 | 57 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.61e-05 | 187 | 57 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-05 | 188 | 57 | 4 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 190 | 57 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.04e-04 | 191 | 57 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 191 | 57 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-04 | 192 | 57 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.06e-04 | 192 | 57 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 192 | 57 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 193 | 57 | 4 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.09e-04 | 193 | 57 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 193 | 57 | 4 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 195 | 57 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 196 | 57 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 196 | 57 | 4 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 196 | 57 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 199 | 57 | 4 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 199 | 57 | 4 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 199 | 57 | 4 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 7.50e-05 | 122 | 54 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 2.95e-04 | 14 | 54 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Tetralogy of Fallot | 3.88e-04 | 16 | 54 | 2 | C0039685 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 7.42e-04 | 22 | 54 | 2 | C1843687 | |
| Disease | caudate nucleus volume | 1.38e-03 | 30 | 54 | 2 | EFO_0004830 | |
| Disease | cuneus cortex volume measurement | 1.48e-03 | 31 | 54 | 2 | EFO_0010301 | |
| Disease | atrial fibrillation (is_marker_for) | 1.57e-03 | 32 | 54 | 2 | DOID:0060224 (is_marker_for) | |
| Disease | atopic dermatitis (is_marker_for) | 1.88e-03 | 35 | 54 | 2 | DOID:3310 (is_marker_for) | |
| Disease | response to glucocorticoid, osteonecrosis | 2.33e-03 | 39 | 54 | 2 | EFO_0004259, GO_0051384 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 2.83e-03 | 43 | 54 | 2 | EFO_0007788, EFO_0008343 | |
| Disease | psoriasis (is_marker_for) | 2.96e-03 | 44 | 54 | 2 | DOID:8893 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAAVHCALRSPPPEA | 11 | O43488 | |
| PHRPAQACRKGRPAV | 66 | Q9NTK1 | |
| VARPAEPAPFNKRHC | 36 | C9J069 | |
| RLAPIPRARHDFACA | 586 | P51828 | |
| ASRPEPQVRRCNLHP | 846 | Q8TE56 | |
| DTRDLRPLRPFHCQP | 1491 | Q9UKP4 | |
| RVFPTHPDCPQFSTR | 126 | Q2M243 | |
| RERSCPAASPHPRVR | 21 | A6NCS4 | |
| NPRAHPDRPACSAAA | 66 | Q00444 | |
| TRRPFVPQSCLPHEA | 516 | Q9NPJ1 | |
| PHASFQAAARSPLRP | 81 | Q14774 | |
| LEAPPRAHVAFRPDC | 386 | Q9NRM7 | |
| RAHVAFRPDCPVPSR | 391 | Q9NRM7 | |
| FRRPAREHPPACLSD | 51 | Q8IUS5 | |
| SCPEAPAAHSARPER | 1056 | Q5JYT7 | |
| PCAHPNSRFCAPARQ | 416 | Q16822 | |
| APLPGRPDAFHRCIF | 66 | Q16342 | |
| NRIGRRNYSSPPPCH | 41 | Q12986 | |
| PAPLRVHCPSFRADS | 181 | A6NHZ5 | |
| PFLFGPASRCHQERP | 26 | O96004 | |
| THRPPAPARIADSCA | 486 | Q9P0K8 | |
| VLRREPPHCPNSFRL | 121 | Q16552 | |
| QCLRFPGLAPPHTRA | 651 | Q0VG06 | |
| RPHPGFYRPRLSNCS | 211 | Q9UF02 | |
| PDPGRPAAYRRAHVC | 41 | P59020 | |
| PCPSARARPRHKSLN | 31 | Q9ULE3 | |
| RRSPCPHPVNCYVSR | 186 | P36382 | |
| LSPDCRRRPQFHPSQ | 4446 | Q8TDW7 | |
| CAVPVESDPRHPRAA | 111 | A2IDD5 | |
| RPHPAFYRPRLSDCS | 211 | P62955 | |
| RRCPFRHLGESVPDN | 351 | Q7KYR7 | |
| RSVTPAAKRHQCPFP | 186 | Q8TD94 | |
| PLEPARPNRHPESCR | 61 | Q9H293 | |
| HSFRIRVAACPQAPG | 1031 | Q86VF2 | |
| HPPSPTRDECFARRA | 386 | Q16610 | |
| RPASRAFPQHCRPRD | 21 | A6NKF1 | |
| AFPQHCRPRDAERPP | 26 | A6NKF1 | |
| CRHAVRQRFLPGSPR | 66 | Q3MIP1 | |
| RCDPVPAANGAIRFH | 446 | Q9UPN9 | |
| QRDALRHFAPCQPRA | 121 | Q9H7J1 | |
| RHFAPCQPRARGLQE | 126 | Q9H7J1 | |
| RARCPQSAHPAPTRG | 41 | Q9NV39 | |
| PGENPYRFRDPHQCR | 136 | Q16842 | |
| RRDHRPPCAQEAPRN | 106 | Q13501 | |
| PCPECGRRFRHAPFL | 86 | Q9BWE0 | |
| APPPQRPFRVCDHKR | 31 | Q9UHD4 | |
| PAQRDCSFPGLPRHQ | 336 | O43734 | |
| CSSAPPRPTRRFHTV | 331 | Q96LP6 | |
| RHNKSCARNRCPRPP | 11 | Q1ZZU3 | |
| FHPERPSCPQRSVAD | 321 | Q5D1E8 | |
| PSHRECFLPSVARTP | 11 | Q8IWN7 | |
| TNHRRRFPDQKECPP | 16 | Q9BY07 | |
| AAGRRHFHASQCPRP | 1426 | Q9Y6N7 | |
| RVHPAPGPRCRALFS | 86 | A6NKF7 | |
| LHQFCAQHGRPPRPR | 336 | P22314 | |
| ADRPPANSHRRVCPF | 131 | Q8N446 | |
| RCHQPLARAQPAVRA | 386 | Q15942 | |
| PAARCPRHGRPLELF | 91 | Q6PJ69 | |
| HPCPRCPRRFSRAYS | 441 | Q8NAF0 | |
| FRAVGPAQAHRRCPF | 2701 | Q15911 |